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(Thr28,Nleat)CCK(23-33) (CCK-9) and gastrin(1-17)l (gastrin) inhibited adenylate cyclase activity in membranes from 
the tumoral rat pancreatic a inar cell line AR 4-2J through aBordetella pertussis toxin-sensitive m chanism. This con- 
trasted with the stimulatory effect exerted by CCK-9 on adenylate cyclase activity in membranes from normal rat pan- 
creas. The relative potency of CCK-9, gastrin, and related peptides ininhibiting adenylate cyclase, when confronted with 
previous evidence, suggests hat 'non-selective CCK-gastrin CCK-B receptors' predominating over 'selective CCK-A re- 
ceptors' in the AR 4-2J cell line, favored the coupling of the first receptors toadenylate cyclase through G, while CCK-A 
receptors capable of stimulating the enzyme through Gs were detected only after Bordetella pertussis toxin pretreatment. 
Cholecystokinin receptor; Gastrin receptor; Adenylate cyclase; Guanine nucleotide-binding re ulatory protein; 
Pertussis toxin; (Rat pacreas, Tumoral rat pancreatic cell ine AR 4-2J) 
1. INTRODUCTION 
Cholecystokinin (CCK) receptors are hetero- 
geneous: two classes are currently considered 
based on the relative potency of CCK agonists and 
antagonists and tissular location. 'Peripheral 
CCK-A receptors' located in the pancreas and 
gallbladder smooth muscle show high affinity for 
CCK but low affinity for gastrin and C-terminal 
CCK fragments. Such CCK-A receptors in the nor- 
mal pancreas are likely to exist in two forms: one 
with high affinity for agonists is coupled to 
calcium movements, cyclic GMP production and 
amylase  secretion; the second form displays lower 
affinity for agonists and is coupled to cyclic AMP 
production [1]. CCK-B receptors, found in 
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preference in the central nervous system, are 
characterized by high affinity for both CCK, 
gastrin, and C-terminal gastrin fragments. The se- 
cond messenger of these receptors is unknown but 
might involve adenylate cyclase inhibition in the 
anterior part of the nucleus accumbens of rat 
where CCK inhibits the cyclic AMP increase pro- 
voked by dopamine [2]. 
Having recently demonstrated the coexistence of 
CCK-A and CCK-B receptors in the rat cultured 
tumoral pancreatic acinar cell line AR 4-2J [3], we 
used this model to investigate the possible coupling 
of both receptor types to adenylate cyclase through 
Gs and/or  Gi regulatory proteins. Our results 
demonstrate that CCK, gastrin, and C-terminal 
gastrin fragments inhibited membrane adenylate 
cyclase activity and that this inhibition was no 
longer observed after pretreating the cell line with 
pertussis toxin. These data represent the first in- 
dication of a possible coupling of CCK-B receptors 
to Gi. 
Published by Elsevier Science Publishers B.V. (Biomedical Division) 
00145793/88/$3.50 © 1988 Federation of European Biochemical Societies 61 
Volume 242, number 1 FEBS LETTERS December 1988 
2. MATERIALS AND METHODS 
AR 4-2J cells were grown in Dulbecco's modified Eagle's 
medium supplemented with 10070 (v/v) fetal calf serum, 
penicillin, streptomycin a d fungizone ®, in an atmosphere of
507o CO2 in air at 10007o humidity and were used at confluence. 
Pertussis toxin, prepared as described [4], was kindly given by 
Dr M. Svoboda (Dept of Biochemistry and Nutrition, Medical 
School, Universit6 Libre de Bruxelles) and, when used, was in- 
corporated into the culture medium at a concentration of 
0.1/~g/ml, 18 h before membrane preparation. 
Membranes from control and pertussis toxin-treated AR 4-2J 
cells were prepared as follows. Cells were harvested with a rub- 
ber policeman, pelleted at 200 x g for 5 rain then lysed with 
1 mM bicarbonate and rapid freezing in liquid nitrogen. After 
thawing the suspension was centrifuged at 1000 x g for 10 rain 
and the supernatant was recentrifuged at 15 000 × g for 10 min. 
The resulting pellet was suspended in 1 mM bicarbonate in 
order to obtain a 0.6-1.0 mg protein/ml concentration and 
tested immediately for adenylate cyclase activity. 
A crude preparation of membranes was similarly prepared 
from rat pancreas homogenized in 1 mM bicarbonate. 
Adenylate cyclase activity was determined by the Salomon et al. 
[5] procedure as previously described [6]. Synthetic porcine 
(Thr~S,Nle~)CCK(25-33), human (Leu~)gastrin(2-27) 
desulfated and gastrin(14-17) were gifts from Professor E. 
Wiinsch (Max-Planck-Institut flit Biochemie, Martinsried, 
FRG); VIP and secretin were gifts from, respectively, Dr D.H. 
Coy (Dept of Medicine, Tulane University, New Orleans, LA, 
USA) and Dr W. K6nig (Hoechst Aktiengesellschaft, Frankfurt 
am Main, FRG). Human gastrin(l-17)[ and pentagastrin were 
from CRB Laboratories (Cambridge, England). 
(Thr28,Nlea~)CCK(25-33) and human gastrin(14-17) are refer- 
red to as CCK-9 and tetragastrin i  the present paper. 
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Fig.1. Effects of maximal concentrations (1/tM) of VIP, 
secretin, CCK-9 and gastrin on adenylate cyclase activity in rat 
pancreatic membranes (upper panel) and AR 4-2J membranes 
(lower panel). All assays were performed in the presence of 
10/zM GTP. The results were the means _+ SE of at least 3 
experiments and were expressed in pmol cyclic AMP 
produced- rain- i. mg protein- i.
3. RESULTS 
Adenylate cyclase activity in normal rat pan- 
creatic membranes was stimulated by CCK-9, 
secretin and VIP in the presence of GTP (fig. 1A). 
Secretin had tile highest efficacy. Gastrin at a 
10/zM concentration was inactive. A dose- 
response curve of CCK-9-stimulated adenylate 
cyclase activity in these membranes indicated a Kact 
value (concentration exerting half-maximal 
stimulation) of 0.3/~M. Gastrin, pentagastrin a d 
tetragastrin at 10/zM were ineffective per se and 
unable to inhibit the CCK-9-stimulated adenylate 
cyclase activity (not shown). 
Membranes from AR 4-2J cells showed high 
adenylate cyclase activity in the presence of GTP 
alone; secretin and VIP stimulated this activity, 
1.5- and 2.6-fold, respectively. In contrast, 1/~M 
CCK and 1/zM gastrin inhibited the same activity 
by 30-40% (fig.lB). The dose dependency of 
adenylate cyclase inhibition for 4 selected CCK 
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Fig.2. Dose-effect curves of adenylate cyclase inhibition by 
CCK-9 (z~), gastrin(2-17) non-sulfated (e), pemagastrin (A), 
and tetragastrin (o) in membranes from AR 4-2J cells. The 
results were expressed in °7o of the basal value observed in the 
presence of 10/~M GTP and were the means of at least 3 
experiments. 
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Fig.3. Dose-effect curves of CCK-9 on adenylate cyclase 
activity in membranes from AR 4-2J cells pretreated (o) or not 
(o) with Bordetella pertussis toxin as indicated in section 2. 
agonists and analogues howed the following Ki 
values (concentration i ducing half-maximal in- 
hibition): 20, 300, 10 and 300 nM for, respectively, 
CCK-9, gastrin(2-17) nonsulfated, pentagastrin, 
and tetragastrin (fig.2). Pretreating AR 4-2J cells 
with pertussis toxin for 18 h completely abolished 
the CCK and gastrin inhibition of adenylate 
cyclase and revealed instead a small (+ 15010) but 
significant stimulation of the activity by CCK 
(fig.3) while basal activity and VIP stimulation of 
adenylate cyclase were not altered (not shown). 
4. DISCUSSION 
The present data represent he first direct 
evidence that CCK and gastrin can inhibit 
adenylate cyclase activity through aBordeteila per- 
tussis toxin-sensitive mechanism, i.e. a guanine 
nucleotide-binding regulatory protein of the Gi 
type. This inhibitory effect of CCK and gastrin 
was observed in membranes from a transformed 
rat pancreatic acinar cell line but not in membranes 
from normal rat pancreas where, in contrast, the 
enzymatic activity was stimulated by CCK. This 
absence of CCK inhibition in normal pancreas 
could not be attributed to a lack of Gi since this 
organ contains a41 kDa protein that can be ADP- 
ribosylated in the presence of Bordetella pertussis 
toxin [4]. Our results are, therefore, best explained 
by considering distinct populations of CCK recep- 
tors in AR 4-2J cells and in normal pancreas. 
In AR 4-2J membranes, two types of CCK 
receptors coexist: CCK-preferring receptors of the 
CCK-A type that distinguish CCK and gastrin 
while an equal proportion (50°70) of non-selective 
CCK-B receptors does not discriminate CCK and 
gastrin [3]. This second class of receptors, when 
characterized with radiolabelled gastrin [3], shows 
a relative affinity for CCK, gastrin, pentagastrin 
and tetragastrin similar to that observed in the pre- 
sent study for adenylate cyclase inhibition. 
However, the concentrations required in binding 
studies for receptor occupancy are lower than 
those provoking adenylate cyclase inhibition sug- 
gesting that CCK-B receptors, like selective CCK- 
A receptors, can exist in either a low- or a high- 
affinity state for agonists (see section 1). 
In normal rat pancreas only selective CCK-A 
receptors have been described, their high-affinity 
state being coupled to calcium movements, cyclic 
GMP production, and amylase secretion [1], 
whereas the low-affinity state is coupled to cyclic 
AMP production, inhibition of amylase secretion, 
and increased amino acid transport [7,8]. 
In dog pancreas, the coexistence of CCK-A and 
CCK-B receptors has been reported with CCK-B 
receptors representing 15070 of the total [9]. In 
guinea pig pancreas, 4°70 of CCK receptors can be 
considered to be 'non-selective or gastrin recep- 
tors' [10]. These receptors are not linked to enzyme 
secretion but might be involved in Na+/H + ex- 
change [11] (a phenomenon often linked to 
adenylate cyclase inhibition [12]) and in trophic ef- 
fects [13]. 
To conclude, our data can be tentatively inter- 
preted as follows: AR 4-2J cell membranes are 
characterized byan unusual balance of CCK recep- 
tors favoring non-selective CCK-B receptors. Due 
to their relatively high number and efficient cou- 
pling to a Gi type of regulatory protein, the overall 
effect exerted by CCK-9 on adenylate cyclase was 
inhibitory. After ADP-ribosylation of Gi, the in- 
hibitory effect of CCK-9 disappeared revealing a
potential for CCK-mediated adenylate cyclase 
stimulation, probably through the selective CCK- 
A receptors and Gs. In this respect, it is of interest 
to note that a dual effect of CCK on adenylate 
cyclase has already been observed in rat brain 
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where CCK inhibits dopamine-stimulated adenyl- 
ate cyclase in the anterior part of the nucleus ac- 
cumbens but potentiates the dopamine ffect in the 
posterior part of the area [2]. 
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